M. Gerdis

Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease

Robert P. Anderson, Glenn O. Brown, A. Coates, 2020, BMC Medicine.

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

Glenn O. Brown, M. Mäki, B. Lebwohl, 2020 .

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.

J. Andrews, R. Gearry, G. Holtmann, 2023, The lancet. Gastroenterology & hepatology.